دورية أكاديمية
Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment
| العنوان: | Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment |
|---|---|
| المؤلفون: | Pépin, M., Klimkowicz-Mrowiec, A., Godefroy, O., Delgado, P., Carriazo, S., Ferreira, A.C., Golenia, A., Malyszko, J., Grodzicki, T., Giannakou, K., Paolisso, G., Barbieri, M., Garneata, L., Mocanu, C.A., Liabeuf, S., Spasovski, G., Zoccali, C., Bruchfeld, A., Farinha, A., Arici, M., Capasso, G., Wiecek, A., Massy, Z.A., Andrade, A., Bachmann, M., Bumblyte, I., Covic, A.C., Endlich, N., Engvig, A., Fouque, D., Franssen, C., Frische, S., Gesualdo, L., Goumenos, D., Mani, L.-Y., Marti, H.-P., Mayer, C., Nielsen, R., Pešić, Vesna, Rroji, M., Sakkas, G., Stevens, K., Vazelov, E., Viggiano, D., Zacharia, L., Hoorn, E., Figurek, A., Unwin, R., Wagner, C.A., Wanner, C., Nitsch, D., Fridolin, I., Hafez, G., Soler Romeo, M.J., Batinić, Bojan, Carrasco, L., Gansevoort, R., Martino, G., Mattace Raso, F., Nistor, I., Ortiz, A., Rastenytė, D., Stefan, G., Tedeschi, G., Bikbov, B., Endlich, K.H., Kurganaite, J., Perico, N., Remuzzi, G., Trepiccione, F., Blankestijn, P., Eckardt, K.-U., Fliser, D., Gutiérrez-Jiménez, E., Konig, M., Rychlik, I., Deleidi, M., Reusz, G., Farisco, M., Imenez Silva, P.H., Bobot, M., Capolongo, G. |
| المصدر: | European Journal of Neurology |
| بيانات النشر: | John Wiley and Sons Inc |
| سنة النشر: | 2023 |
| المجموعة: | FarFaR - Pharmacy Repository (Univ. of Belgrade, Fac. of Pharmacy) |
| مصطلحات موضوعية: | chronic kidney disease, cognition, dialysis, glomerular filtration rate, vascular risk factors |
| الوصف: | Background: Cognitive impairment is common in patients with chronic kidney disease (CKD), and early intervention may prevent the progression of this condition. Methods: Here, we review interventions for the complications of CKD (anemia, secondary hyperparathyroidism, metabolic acidosis, harmful effects of dialysis, the accumulation of uremic toxins) and for prevention of vascular events, interventions that may potentially be protective against cognitive impairment. Furthermore, we discuss nonpharmacological and pharmacological methods to prevent cognitive impairment and/or minimize the latter's impact on CKD patients' daily lives. Results: A particular attention on kidney function assessment is suggested during work-up for cognitive impairment. Different approaches are promising to reduce cognitive burden in patients with CKD but the availabe dedicated data are scarce. Conclusions: There is a need for studies assessing the effect of interventions on the cognitive function of patients with CKD. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | unknown |
| تدمد: | 1351-5101 |
| العلاقة: | COST Action CA19127; COST (European Cooperation in Science and Technology; Personal fees from AstraZeneca, Bayer, ChemoCentryx, and Vifor. A.C.F.; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5594Test; 001022298400001; 2-s2.0-85163668939; http://farfar.pharmacy.bg.ac.rs/bitstream/id/15799/Cognitive_disorders_in_pub_2023.pdfTest |
| DOI: | 10.1111/ene.15928 |
| الإتاحة: | https://doi.org/10.1111/ene.15928Test https://farfar.pharmacy.bg.ac.rs/handle/123456789/5594Test http://farfar.pharmacy.bg.ac.rs/bitstream/id/15799/Cognitive_disorders_in_pub_2023.pdfTest |
| حقوق: | openAccess ; https://creativecommons.org/licenses/by-nc-nd/4.0Test/ ; BY-NC-ND |
| رقم الانضمام: | edsbas.18A80DD5 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 13515101 |
|---|---|
| DOI: | 10.1111/ene.15928 |